The monoclonal antibodies against TNF (Remicade, Humira) appear to work much better for Crohn’s disease compared with Enbrel, a soluble receptor that binds TNF. All three drugs clear TNF from the circulation so why this is, is not completely understood. Some have postulated that the size of the drug molecule has an effect, with the monoclonal antibodies being much smaller and this able to penetrate the tissues better, In addition, there may be differnces between the drugs for the treatment of skin psoriasis as well.
A Small Favor
More than 15 years ago the Arthritis Center launched this website with the mission to bring current and accurate disease education to health care professionals and patients alike. Content on our site is generated directly by our team members. Unlike many health education websites we do not accept advertising, paid guests posts or charge for access to our site.
That’s where you come in. Your support will allow us to continue to deliver this valuable information to over 1 million visitors each year.Contribute TodayMore Ways to Give